4.5 Article

Advanced diffusion imaging to track progression in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson's disease

Angeliki Zarkali et al.

Summary: Patients with Parkinson's disease hallucinations show significant white matter changes, particularly in posterior connections and thalamic nuclei. Cortical thickness changes are less extensive. Thalamic nucleus of the right medial mediodorsal showed both connectivity and volume loss in PD hallucinations.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Article Neurosciences

Microstructural Tissue Changes in a Rat Model of Mild Traumatic Brain Injury

Karthik Chary et al.

Summary: Our study investigates the potential of diffusion MRI methods in detecting microstructural tissue abnormalities in rats after mTBI, revealing extensive changes in both directly affected and distal brain areas. The combination of DTI, FBA, and NODDI provides a comprehensive insight into white and gray matter alterations after mild traumatic brain injury, aiding in diagnosis and prognosis.

FRONTIERS IN NEUROSCIENCE (2021)

Article Geriatrics & Gerontology

In vivo coupling of dendritic complexity with presynaptic density in primary tauopathies

Elijah Mak et al.

Summary: The study found that patients with PSP-RS and CBD have widespread reductions in cortical ODI and non-displaceable binding potential of [C-11]UCB-J, which are more severe and extensive than atrophy. Regional cortical ODI was significantly associated with [C-11]UCB-J BPND in disease-associated regions. This furthers our understanding of the pathophysiology of neurodegeneration.

NEUROBIOLOGY OF AGING (2021)

Article Geriatrics & Gerontology

Fixel-Based Analysis of White Matter Degeneration in Patients With Progressive Supranuclear Palsy or Multiple System Atrophy, as Compared to Parkinson's Disease

Thanh-Thao Nguyen et al.

Summary: The study found significant differences in patterns of white matter degeneration between PD and MSA, PSP patients, with MSA and PSP patients showing more extensive white matter involvement. FBA identified specific patterns of white matter changes in MSA and PSP patients compared to PD, highlighting its utility in evaluating underlying biological processes in parkinsonism.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Review Clinical Neurology

Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease A Review

Trina Mitchell et al.

Summary: Imaging biomarkers for different stages of Parkinson's disease are crucial for monitoring progression in clinical trials and improving clinical care. This review highlights the importance of considering disease stage when implementing diagnostic and progression biomarkers in both clinical trials and clinical care settings.

JAMA NEUROLOGY (2021)

Article Clinical Neurology

MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy

Jennifer L. Whitwell et al.

MOVEMENT DISORDERS (2019)

Review Clinical Neurology

Imaging of Motor Cortex Physiology in Parkinson's Disease

Roxana G. Burciu et al.

MOVEMENT DISORDERS (2018)

Article Clinical Neurology

Progression marker of Parkinson's disease: a 4-year multi-site imaging study

Roxana G. Burciu et al.

BRAIN (2017)

Article Clinical Neurology

Free-water imaging in Parkinson's disease and atypical parkinsonism

Peggy J. Planetta et al.

BRAIN (2016)

Article Clinical Neurology

Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease

Gaetano Barbagallo et al.

MOVEMENT DISORDERS (2016)

Article Neurosciences

A probabilistic atlas of the cerebellar white matter

K. M. van Baarsen et al.

NEUROIMAGE (2016)

Article Neurosciences

Denoising of diffusion MRI using random matrix theory

Jelle Veraart et al.

NEUROIMAGE (2016)

Article Clinical Neurology

Progression of brain atrophy in PSP and CBS over 6 months and 1 year

Shubir Dutt et al.

NEUROLOGY (2016)

Article Clinical Neurology

Expanding the spectrum of neuronal pathology in multiple system atrophy

Matthew D. Cykowski et al.

BRAIN (2015)

Article Geriatrics & Gerontology

Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study

Edward Ofori et al.

NEUROBIOLOGY OF AGING (2015)

Article Medicine, Research & Experimental

Parkinson's Disease and Parkinsonism: Neuropathology

Dennis W. Dickson

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Article Neurosciences

Symmetric diffeomorphic registration of fibre orientation distributions

David Raffelt et al.

NEUROIMAGE (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

Free Water Elimination and Mapping from Diffusion MRI

Ofer Pasternak et al.

MAGNETIC RESONANCE IN MEDICINE (2009)

Article Clinical Neurology

Second consensus statement on the diagnosis of multiple system atrophy

S. Gilman et al.

NEUROLOGY (2008)

Article Clinical Neurology

A clinical rating scale for progressive supranuclear palsy

Lawrence I. Golbe et al.

BRAIN (2007)

Article Geriatrics & Gerontology

The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment

ZS Nasreddine et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)

Article Clinical Neurology

Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)

GK Wenning et al.

MOVEMENT DISORDERS (2004)

Review Geriatrics & Gerontology

Staging of brain pathology related to sporadic Parkinson's disease

H Braak et al.

NEUROBIOLOGY OF AGING (2003)

Review Ophthalmology

Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review

Evita Evangelia Christou et al.

Summary: The retina may serve as a predictive factor for neurodegenerative disorders, with recent use of Optical Coherence Tomography Angiography (OCT-A) in studying macular microcirculation changes in Parkinson's disease (PD). While preliminary evidence suggests OCT-A could be a useful biomarker for cerebral vasculature in PD, further research is needed to confirm its predictive value in clinical practice.

SEMINARS IN OPHTHALMOLOGY